StockUnited StatesNasdaqGS

GILD

Gilead Sciences, Inc.

Healthcare · Drug Manufacturers - General

156.04USD

-1.1500 (-0.73%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

In $M except per-share	Q2 FY26	Q1 FY26	Q4 FY25*	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24*	Q3 FY24
Revenue	7,803	6,960	7,925	7,769	7,082	6,667	7,569	7,545
Cost of Revenue	1,579	1,445	1,624	1,569	1,501	1,540	1,581	1,574
Gross Profit	6,224	5,515	6,301	6,200	5,581	5,127	5,988	5,971
Operating Income	-10,394	2,586	1,984	3,327	2,474	2,237	2,452	888
Net Income	-10,496	2,021	2,183	3,052	1,960	1,315	1,783	1,253
EPS (Diluted)	-$8.45	$1.61	$1.74	$2.43	$1.56	$1.04	$1.42	$1.00

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)

Fetching financial statements from SEC filings…